Fulton Breakefield Broenniman LLC Pfizer Inc Transaction History

Fulton Breakefield Broenniman LLC

$1.41 Billion
Q3 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 8,989 shares of PFE stock, worth $236,950. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,989

Previous 9,102 1.24%

Holding current value

$236,950

Previous $254,000 2.36%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$27.7 - $31.39 $3,130 - $3,547	-113 Reduced 1.24%	8,989 $260,000
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $87,930 - $103,037	-3,481 Reduced 27.66%	9,102 $254,000
Q1 2024 Apr 29, 2024	BUY	$25.89 - $29.73 $31,896 - $36,627	1,232 Added 10.85%	12,583 $349,000
Q4 2023 Feb 02, 2024	SELL	$26.13 - $33.94 $2,038 - $2,647	-78 Reduced 0.68%	11,351 $326,000
Q3 2023 Oct 20, 2023	SELL	$32.09 - $37.51 $26,442 - $30,908	-824 Reduced 6.72%	11,429 $379,000
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $24,886 - $28,793	-689 Reduced 5.32%	12,253 $449,000
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $5.94 Million - $7.73 Million	-150,820 Reduced 92.1%	12,942 $528,000
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $17,159 - $22,399	411 Added 0.25%	163,762 $8.39 Million
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $53,693 - $65,546	-1,227 Reduced 0.75%	163,351 $7.15 Million
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $224,739 - $266,471	-4,830 Reduced 2.85%	164,578 $8.63 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $29,600 - $36,678	647 Added 0.38%	169,408 $8.77 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $60,823 - $90,160	1,472 Added 0.88%	168,761 $9.97 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $153,389 - $197,041	-3,908 Reduced 2.28%	167,289 $7.2 Million
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $5.07 Million - $5.75 Million	-141,285 Reduced 45.21%	171,197 $6.7 Million
Q1 2021 Apr 09, 2021	BUY	$33.49 - $37.77 $1.4 Million - $1.57 Million	41,663 Added 15.38%	312,482 $11.3 Million
Q4 2020 Jan 14, 2021	SELL	$33.47 - $42.56 $1.45 Million - $1.84 Million	-43,238 Reduced 13.77%	270,819 $9.97 Million
Q3 2020 Oct 20, 2020	SELL	$31.75 - $37.25 $110,299 - $129,406	-3,474 Reduced 1.09%	314,057 $11.5 Million
Q2 2020 Jul 10, 2020	BUY	$30.12 - $36.54 $93,191 - $113,054	3,094 Added 0.98%	317,531 $10.4 Million
Q1 2020 Apr 10, 2020	SELL	$27.03 - $38.62 $85,090 - $121,575	-3,148 Reduced 0.99%	314,437 $10.3 Million
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $292,362 - $331,794	8,881 Added 2.88%	317,585 $12.4 Million
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $247,411 - $320,819	7,615 Added 2.53%	308,704 $11.1 Million
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $83,796 - $94,084	2,266 Added 0.76%	301,089 $13 Million
Q1 2019 Apr 17, 2019	BUY	$37.5 - $41.2 $25,125 - $27,604	670 Added 0.22%	298,823 $12.7 Million
Q4 2018 Feb 05, 2019	BUY	$38.47 - $43.86 $33,853 - $38,596	880 Added 0.3%	298,153 $13 Million
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $75,351 - $91,396	-2,186 Reduced 0.73%	297,273 $13.1 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $3,561 - $3,797	108 Added 0.04%	299,459 $10.9 Million
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $158,177 - $183,508	-4,957 Reduced 1.63%	299,351 $10.6 Million
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $27,439 - $29,114	825 Added 0.27%	304,308 $11 Million
Q3 2017 Oct 13, 2017	BUY	$31.0 - $34.15 $9.41 Million - $10.4 Million	303,483	303,483 $10.8 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Pfizer Inc Transaction History